Ammonium peroxydisulphate ≥98 %, p.a., ACS

Hazard statements (CLP)

H272, H302, H315, H317, H319, H334, H335

Code

Statements

H272

May intensify fire; oxidiser

SECTION 2: Hazards identification

According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture

Hazard categories

Cat- Hazard class and Hazard egory category statement 2.14 Oxidising solid Ox. Sol. 3 H272 3.1O Acute toxicity (oral) Acute Tox. 4 H302 3.2 Skin corrosion/irritation Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation Eye Irrit. 2 H319 3.4R Respiratory sensitisation Resp. Sens. 1 H334 3.4S Skin sensitisation Skin Sens. 1 H317 3.8R Specific target organ toxicity - single exposure (respir- STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16

Signal word

Danger Danger Not required

Hazard pictograms

GHS03, GHS07, GHS08 H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. P261 Avoid breathing mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 IF ON SKIN: Wash with plenty of water. Labelling of packages where the contents do not exceed 10 ml

Hazard statements

H272 May intensify fire; oxidiser H302 Harmful if swallowed H315 Causes skin irritation H317 May cause an allergic skin reaction H319 Causes serious eye irritation H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled H335 May cause respiratory irritation Not required

Prevention

P261 Avoid breathing mist/vapours/spray P280 Wear protective gloves/protective clothing/eye protection/face protection

Response

P302+P352 IF ON SKIN: Wash with plenty of water P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P332+P313 If skin irritation occurs: Get medical advice/attention P337+P313 If eye irritation persists: Get medical advice/attention Labelling of packages where the contents do not exceed 125 ml

Precautionary statements

Not required

Results of PBT and vPvB assessment

According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 2.14 Oxidising solid 3 Ox. Sol. 3 H272 3.1O Acute toxicity (oral) 4 Acute Tox. 4 H302 3.2 Skin corrosion/irritation 2 Skin Irrit. 2 H315 3.3 Serious eye damage/eye irritation 2 Eye Irrit. 2 H319 3.4R Respiratory sensitisation 1 Resp. Sens. 1 H334 3.4S Skin sensitisation 1 Skin Sens. 1 H317 3.8R Specific target organ toxicity - single exposure (respir- 3 STOT SE 3 H335 atory tract irritation) For full text of abbreviations: see SECTION 16